NATURAL CAPSULES Financial Statement Analysis
|
||
The Revenues of NATURAL CAPSULES have increased by 27.62% YoY .
The Earnings Per Share (EPS) of NATURAL CAPSULES has increased by 1.33 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
NATURAL CAPSULES Last 5 Annual Financial Results
[BOM: 524654]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹172 Cr | ₹135 Cr | ₹80 Cr | ₹62 Cr | ₹60 Cr |
Expenses | ₹138 Cr | ₹111 Cr | ₹68 Cr | ₹56 Cr | ₹55 Cr |
Operating Profit (Excl OI) | ₹34 Cr | ₹24 Cr | ₹11 Cr | ₹5.45 Cr | ₹5.05 Cr |
Other Income | ₹1.62 Cr | ₹2.22 Cr | ₹0.73 Cr | ₹0.95 Cr | ₹1.14 Cr |
Interest | ₹3.73 Cr | ₹2.08 Cr | ₹0.54 Cr | ₹0.91 Cr | ₹0.53 Cr |
Depreciation | ₹7.21 Cr | ₹5.04 Cr | ₹4.31 Cr | ₹4.12 Cr | ₹3.20 Cr |
Profit Before Tax | ₹25 Cr | ₹19 Cr | ₹9.16 Cr | ₹1.37 Cr | ₹2.07 Cr |
Profit After Tax | ₹18 Cr | ₹14 Cr | ₹6.91 Cr | ₹0.86 Cr | ₹1.92 Cr |
Consolidated Net Profit | ₹18 Cr | ₹14 Cr | ₹6.85 Cr | ₹0.86 Cr | ₹1.92 Cr |
Earnings Per Share (Rs) | ₹19.82 | ₹19.56 | ₹10.99 | ₹1.38 | ₹3.08 |
PAT Margin (%) | 10.70 | 10.30 | 8.69 | 1.39 | 3.21 |
ROE(%) | 17.89 | 19.18 | 11.74 | 1.54 | 3.50 |
ROCE(%) | 16.18 | 20.75 | 14.52 | 3.71 | 4.51 |
Total Debt/Equity(x) | 0.78 | 0.63 | 0.16 | 0.11 | 0.10 |
Key Financials |
||
Market Cap | : | ₹ 284.1 Cr |
Revenue (TTM) | : | ₹ 152.8 Cr |
Net Profit(TTM) | : | ₹ 7.3 Cr |
EPS (TTM) | : | ₹ 7.8 |
P/E (TTM) | : | 39.2 |
Industry Peers & Returns | 1W | 1M | 1Y |
NATURAL CAPSULES | -5.5% | -6.5% | -25.8% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
NATURAL CAPSULES Revenues
[BOM: 524654]
Y-o-Y | 27.62 % |
5 Yr CAGR | 30.31 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹172 Cr | 27.62 | |
Mar2022 | ₹135 Cr | 69.86 | |
Mar2021 | ₹80 Cr | 29.18 | |
Mar2020 | ₹62 Cr | 2.97 | |
Mar2019 | ₹60 Cr | - |
NATURAL CAPSULES Operating Profit
[BOM: 524654]
Y-o-Y | 41.27 % |
5 Yr CAGR | 61.43 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹34 Cr | 41.27 | |
Mar2022 | ₹24 Cr | 118.83 | |
Mar2021 | ₹11 Cr | 103.80 | |
Mar2020 | ₹5.45 Cr | 7.80 | |
Mar2019 | ₹5.05 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 10.73 % |
5 Yr CAGR | 23.89 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 19.91% | 10.73 | |
Mar2022 | 17.98% | 28.80 | |
Mar2021 | 13.96% | 57.74 | |
Mar2020 | 8.85% | 4.73 | |
Mar2019 | 8.45% | - |
NATURAL CAPSULES Profit After Tax
[BOM: 524654]
Y-o-Y | 34.01 % |
5 Yr CAGR | 75.90 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹18 Cr | 34.01 | |
Mar2022 | ₹14 Cr | 100.29 | |
Mar2021 | ₹6.85 Cr | 698.14 | |
Mar2020 | ₹0.86 Cr | -55.31 | |
Mar2019 | ₹1.92 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | 3.88 % |
5 Yr CAGR | 35.12 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 10.7 % | 3.88 | |
Mar2022 | 10.3 % | 18.53 | |
Mar2021 | 8.69 % | 525.18 | |
Mar2020 | 1.39 % | -56.70 | |
Mar2019 | 3.21 % | - |
NATURAL CAPSULES Earnings Per Share (EPS)
[BOM: 524654]
Y-o-Y | 1.33 % |
5 Yr CAGR | 59.27 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹20 | 1.33 | |
Mar2022 | ₹20 | 77.98 | |
Mar2021 | ₹11 | 696.38 | |
Mar2020 | ₹1.38 | -55.19 | |
Mar2019 | ₹3.08 | - |
NATURAL CAPSULES Return on Capital Employed (ROCE)
[BOM: 524654]
Y-o-Y | -22.02 % |
5 Yr CAGR | 37.63 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 16.18% | -22.02 | |
Mar2022 | 20.75% | 42.91 | |
Mar2021 | 14.52% | 291.37 | |
Mar2020 | 3.71% | -17.74 | |
Mar2019 | 4.51% | - |
NATURAL CAPSULES Share Price vs Sensex
Current Share Price | : | ₹305.5 |
Current MarketCap | : | ₹ 284.1 Cr |
Updated EOD on | : | Mar 28,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATURAL CAPSULES | -5.5% |
-6.5% |
-25.8% |
SENSEX | -0.4% |
-0.9% |
25.8% |
NATURAL CAPSULES related INDICES
You may also like the below Video Courses
FAQ about NATURAL CAPSULES Financials
How the annual revenues of NATURAL CAPSULES have changed ?
The Revenues of NATURAL CAPSULES have increased by 27.62% YoY .
How the Earnings per Share (EPS) of NATURAL CAPSULES have changed?
The Earnings Per Share (EPS) of NATURAL CAPSULES has increased by 1.33 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs